Detalhe da pesquisa
1.
Enhancing Pharmacovigilance in Sub-Saharan Africa Through Training and Mentoring: A GSK Pilot Initiative in Malawi.
Drug Saf
; 43(6): 583-593, 2020 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-32239447
2.
Safety and immunogenicity of the RTS,S/AS01 malaria vaccine in infants and children identified as HIV-infected during a randomized trial in sub-Saharan Africa.
Vaccine
; 38(4): 897-906, 2020 01 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-31708182
3.
Long-term incidence of severe malaria following RTS,S/AS01 vaccination in children and infants in Africa: an open-label 3-year extension study of a phase 3 randomised controlled trial.
Lancet Infect Dis
; 19(8): 821-832, 2019 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-31300331
4.
Safety profile of the RTS,S/AS01 malaria vaccine in infants and children: additional data from a phase III randomized controlled trial in sub-Saharan Africa.
Hum Vaccin Immunother
; 15(10): 2386-2398, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31012786
5.
Ad35.CS.01-RTS,S/AS01 Heterologous Prime Boost Vaccine Efficacy against Sporozoite Challenge in Healthy Malaria-Naïve Adults.
PLoS One
; 10(7): e0131571, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26148007